Noninvasive Measures in Wheezy Infants and Toddlers
喘息婴幼儿的无创治疗
基本信息
- 批准号:7103668
- 负责人:
- 金额:$ 12.66万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-08-01 至 2010-07-31
- 项目状态:已结题
- 来源:
- 关键词:asthmabiomarkerbreath compositionbreath testsbronchodilatorsclinical researchdiagnosis design /evaluationdisease /disorder proneness /riskearly diagnosishuman subjectinfant human (0-1 year)inflammationleukotrieneslongitudinal human studynitric oxidenoninvasive diagnosispatient oriented researchrespiratory airflow disorderrespiratory airway volumerespiratory disorder chemotherapyrespiratory disorder diagnosisrespiratory disorder epidemiologyrespiratory epitheliumrespiratory function
项目摘要
DESCRIPTION (provided by applicant):
Recurrent wheezing is common in early childhood, affecting over 20% of children. Noninvasive methods to diagnosis airflow obstruction and airway inflammation are lacking in infants and toddlers, making it difficult for clinicians to separate transient wheezing of early childhood from early persistent asthma. If such methods were available they would assist medical care providers with the early diagnosis of asthma, provide a rationale basis for the initiation of daily inhaled corticosteroids, and perhaps reduce early decline in lung function through timely therapeutic intervention.
The overall goal of this research is to characterize longitudinal noninvasive measures of airway inflammation and airflow obstruction in a cohort of infants with a history of recurrent wheezing/and age- matched healthy infants. Dr. Debley will assess the associations of longitudinal measurements of exhaled nitric oxide, cysteinyl leukotrienes in exhaled breath condensate, and the thoracic index (an anthropometric measure of pulmonary hyperinflation), with symptoms and infant pulmonary function measures using the raised-volume rapid thoracic compression technique. He will also compare longitudinal values of these noninvasive measures between infants with recurrent wheezing and infants without respiratory symptoms.
Dr. Debley's career goal is to become a leader within the subspecialty of pediatric pulmonology in the study of children with recurrent wheezing, with particular expertise in the non-invasive assessment of airflow obstruction and airway inflammation in young children. He proposes a rigorous 5 year career development plan supervised by four outstanding and experienced mentors, which will provide him with enhanced skills and knowledge in several new areas relevant to his research plan and career goals, including: the performance and interpretation of infant lung function using the raised-volume thoracic compression technique, the collection of exhaled breath condensate and analysis of its constituents, the application of statistical methods used to analyze longitudinal data, a comprehensive understanding of nitric oxide biology including the analysis of exhaled nitric oxide in young children, and a detailed understanding of inflammatory mediators in asthma.
描述(由申请人提供):
反复喘息在幼儿期很常见,影响超过20%的儿童。婴幼儿缺乏诊断气流阻塞和气道炎症的非侵入性方法,这使得临床医生很难将儿童早期短暂性喘息与早期持续性哮喘分开。如果这种方法是可用的,他们将协助医疗保健提供者与哮喘的早期诊断,提供了一个合理的基础上开始每日吸入皮质类固醇,并可能减少早期下降的肺功能,通过及时的治疗干预。
本研究的总体目标是在一组有反复喘息病史的婴儿和年龄匹配的健康婴儿中描述气道炎症和气流阻塞的纵向无创测量。 Debley博士将评估呼出气中一氧化氮、呼出气冷凝液中半胱氨酰白三烯和胸廓指数(肺过度充气的人体测量)的纵向测量值与症状和使用升容快速胸部按压技术测量的婴儿肺功能的相关性。他还将比较反复喘息和无呼吸道症状的婴儿之间这些非侵入性测量的纵向值。
博士Debley的职业目标是成为儿科肺病学亚专业中反复喘息儿童研究的领导者,特别是在幼儿气流阻塞和气道炎症的非侵入性评估方面的专业知识。他提出了一个严格的5年职业发展计划,由四位杰出而经验丰富的导师监督,这将为他提供与他的研究计划和职业目标相关的几个新领域的增强技能和知识,包括:使用增加容量胸部按压技术进行婴儿肺功能的表现和解释,呼出气冷凝物的收集及其成分分析,应用统计学方法分析纵向数据,全面了解一氧化氮生物学,包括幼儿呼出的一氧化氮分析,并详细了解哮喘中的炎症介质。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JASON S DEBLEY其他文献
JASON S DEBLEY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JASON S DEBLEY', 18)}}的其他基金
Dysregulated asthmatic epithelial interferon responses to viruses drive exacerbation, T2 inflammation, and airway remodeling
哮喘上皮干扰素对病毒的反应失调会导致病情加重、T2 炎症和气道重塑
- 批准号:
10558633 - 财政年份:2022
- 资助金额:
$ 12.66万 - 项目类别:
Dysregulated asthmatic epithelial interferon responses to viruses drive exacerbation, T2 inflammation, and airway remodeling
哮喘上皮干扰素对病毒的反应失调会导致病情加重、T2 炎症和气道重塑
- 批准号:
10446799 - 财政年份:2022
- 资助金额:
$ 12.66万 - 项目类别:
Clinical Impacts of Heterogeneous Interferon Responses to Viral Infection by Asthmatic Airway Epithelium
异质干扰素对哮喘气道上皮病毒感染反应的临床影响
- 批准号:
10265757 - 财政年份:2020
- 资助金额:
$ 12.66万 - 项目类别:
Clinical Impacts of Heterogeneous Interferon Responses to Viral Infection by Asthmatic Airway Epithelium
异质干扰素对哮喘气道上皮病毒感染反应的临床影响
- 批准号:
10552683 - 财政年份:2020
- 资助金额:
$ 12.66万 - 项目类别:
Clinical Impacts of Heterogeneous Interferon Responses to Viral Infection by Asthmatic Airway Epithelium
异质干扰素对哮喘气道上皮病毒感染反应的临床影响
- 批准号:
10330561 - 财政年份:2020
- 资助金额:
$ 12.66万 - 项目类别:
Dysregulated Airway Epithelial Signaling as a Driver of Airway Remodeling in Asthmatic Children
气道上皮信号失调是哮喘儿童气道重塑的驱动因素
- 批准号:
9130413 - 财政年份:2015
- 资助金额:
$ 12.66万 - 项目类别:
NONINVASIVE MEASURES OF AIRWAY INFLAMMAITON AND AIRFLOW OBSTRUCTION IN WHEEZY
喘息时气道炎症和气流阻塞的非侵入性治疗
- 批准号:
7603558 - 财政年份:2007
- 资助金额:
$ 12.66万 - 项目类别:
AIRFLOW OBSTRUCTION AND BIOMARKERS OF AIRWAY DURING AND FOLLOWING OF ASTHMA
哮喘期间和之后的气流阻塞和气道生物标志物
- 批准号:
7603551 - 财政年份:2007
- 资助金额:
$ 12.66万 - 项目类别:
AIRFLOW OBSTRUCTION AND BIOMARKERS OF AIRWAY INFLAMATION
气流阻塞和气道炎症的生物标志物
- 批准号:
7379438 - 财政年份:2006
- 资助金额:
$ 12.66万 - 项目类别:
Noninvasive Measures in Wheezy Infants and Toddlers
喘息婴幼儿的无创治疗
- 批准号:
6956540 - 财政年份:2005
- 资助金额:
$ 12.66万 - 项目类别:
相似国自然基金
基于DNA甲基化交互网络的癌症hallmark挖掘及其在癌症转移biomarker筛选中的应用
- 批准号:61602201
- 批准年份:2016
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
血清miRNAs成为一种新的biomarker在PD诊断中的价值和LRRK2基因调控的机制研究
- 批准号:81170309
- 批准年份:2011
- 资助金额:50.0 万元
- 项目类别:面上项目
生物标志物NGAL和KIM-1分子在急性肾损伤中的作用机制研究及标志物联合检测对早期诊断AKI的作用
- 批准号:81101308
- 批准年份:2011
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
精神分裂症记忆障碍的脑网络组学研究
- 批准号:91132301
- 批准年份:2011
- 资助金额:350.0 万元
- 项目类别:重大研究计划
卵巢癌血浆microRNA潜在标志物筛选及调控机制研究
- 批准号:81072363
- 批准年份:2010
- 资助金额:32.0 万元
- 项目类别:面上项目
高原人群创伤性深静脉血栓血浆预测诊断蛋白标记物的发掘
- 批准号:81060151
- 批准年份:2010
- 资助金额:25.0 万元
- 项目类别:地区科学基金项目
非小细胞肺癌Biomarker的Imaging MS研究新方法
- 批准号:30672394
- 批准年份:2006
- 资助金额:30.0 万元
- 项目类别:面上项目
相似海外基金
酸化ストレス応答アポトーシス誘導蛋白のUCに対する新規Biomarker探索と治療への展開
寻找治疗 UC 的氧化应激反应性凋亡诱导蛋白的新生物标志物并开发治疗方法
- 批准号:
24K11919 - 财政年份:2024
- 资助金额:
$ 12.66万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
肝内胆管癌新規Biomarkerの同定及び癌周囲間質を標的とした新規治療開発
鉴定肝内胆管癌的新型生物标志物并开发针对癌周基质的新疗法
- 批准号:
24K19350 - 财政年份:2024
- 资助金额:
$ 12.66万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
収縮能が保たれた心不全の機械学習分類とmicroRNAなどのbiomarkerの探索
机器学习对具有保留收缩性的心力衰竭进行分类并搜索 microRNA 等生物标志物
- 批准号:
24K19007 - 财政年份:2024
- 资助金额:
$ 12.66万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Phase Ib/II study of safety and efficacy of EZH2 inhibitor, tazemetostat, and PD-1 blockade for treatment of advanced non-small cell lung cancer
EZH2 抑制剂、他泽美司他和 PD-1 阻断治疗晚期非小细胞肺癌的安全性和有效性的 Ib/II 期研究
- 批准号:
10481965 - 财政年份:2024
- 资助金额:
$ 12.66万 - 项目类别:
Development of a predictive biomarker for Parkinson's disease
帕金森病预测生物标志物的开发
- 批准号:
MR/Y019415/1 - 财政年份:2024
- 资助金额:
$ 12.66万 - 项目类别:
Research Grant
Sleep and circadian dysfunction in ageing and neurodegeneration: a life course and biomarker study of the British 1946 birth cohort.
衰老和神经退行性疾病中的睡眠和昼夜节律功能障碍:对英国 1946 年出生队列的生命历程和生物标志物研究。
- 批准号:
MR/Y009452/1 - 财政年份:2024
- 资助金额:
$ 12.66万 - 项目类别:
Fellowship
Naturalistic Social Communication in Autistic Females: Identification of Speech Prosody Markers
自闭症女性的自然社交沟通:语音韵律标记的识别
- 批准号:
10823000 - 财政年份:2024
- 资助金额:
$ 12.66万 - 项目类别:
Biomarker-Based Platform for Early Diagnosis of Chronic Liver Disease to Enable Personalized Therapy (LIVERAIM)
基于生物标志物的慢性肝病早期诊断平台,以实现个性化治疗(LIVERAIM)
- 批准号:
10087822 - 财政年份:2024
- 资助金额:
$ 12.66万 - 项目类别:
EU-Funded
Enhanced stratification of COPD patients via integration of a digitally enabled biomarker Point-of-Care test within a Remote Patient Monitoring tool
通过在远程患者监测工具中集成数字化生物标志物即时检测,增强 COPD 患者的分层
- 批准号:
10098600 - 财政年份:2024
- 资助金额:
$ 12.66万 - 项目类别:
Collaborative R&D
QuBIE: Quantitative Biomarker Identification for Non-Endoscopic Prediction and Monitoring of Treatment Response in Eosinophilic Oesophagitis
QuBIE:用于非内镜预测和监测嗜酸性食管炎治疗反应的定量生物标志物鉴定
- 批准号:
10083253 - 财政年份:2024
- 资助金额:
$ 12.66万 - 项目类别:
Collaborative R&D














{{item.name}}会员




